119 followers
RT @Brandon_Beaber: COVID-19 antibodies before and after vaccination in people with MS based on the medication they take. B-cell depleters…
182 followers
RT @Brandon_Beaber: Does gilenya (and zeposia, mayzent) block the t-cell response to COVID-19 vaccines? This study finds that it suppresse…
6,745 followers
RT @Brandon_Beaber: COVID-19 antibodies before and after vaccination in people with MS based on the medication they take. B-cell depleters…
379 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
210 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
263 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
328 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
5,162 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
10,784 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
12,206 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
130 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
290 followers
RT @AaronBosterMD: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - Pu…
12,630 followers
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity - PubMed https://t.co/Y6bGO9mYi3
467 followers
RT @Brandon_Beaber: Does gilenya (and zeposia, mayzent) block the t-cell response to COVID-19 vaccines? This study finds that it suppresse…
5,449 followers
RT @Brandon_Beaber: Does gilenya (and zeposia, mayzent) block the t-cell response to COVID-19 vaccines? This study finds that it suppresse…
4,521 followers
RT @Brandon_Beaber: COVID-19 antibodies before and after vaccination in people with MS based on the medication they take. B-cell depleters…
27 followers
RT @Brandon_Beaber: COVID-19 antibodies before and after vaccination in people with MS based on the medication they take. B-cell depleters…
2,862 followers
RT @Brandon_Beaber: COVID-19 antibodies before and after vaccination in people with MS based on the medication they take. B-cell depleters…
177 followers
16,163 followers
Does gilenya (and zeposia, mayzent) block the t-cell response to COVID-19 vaccines? This study finds that it suppresses the CD4 (helper t-cell) response but not the CD8 (cytotoxic t-cell) response. B-cell depleters (ie ocrevus, rituximab) have no effect h
213 followers
RT @Brandon_Beaber: COVID-19 antibodies before and after vaccination in people with MS based on the medication they take. B-cell depleters…
16,163 followers
COVID-19 antibodies before and after vaccination in people with MS based on the medication they take. B-cell depleters (rituximab, ocrevus, kesimpta) and S1P durgs (gilenya, mayzent, zeposia) suppress antibodies. Other drugs don't. https://t.co/nn9VmRVas
467 followers
New article: Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity https://t.co/2WnFCeOTjv #MS #multiplesclerosis #neurology https://t.co/krQuSxPQ4H
361 followers
The preprint “Impact of multiple sclerosis disease-modifying the…” (https://t.co/QO8kQsUmcR) has been reviewed by automated tools, find results here: https://t.co/CVlFb3DuIr. We detected 1 of 5 rigor criteria, 3 resources, and no limitations statement.
676 followers
RT @jsabatino37: Very proud to share the pre-print of a study I co-led with Riley Bove, @ZamvilScott, and Michael Wilson looking at antibod…
602 followers
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity https://t.co/hsfeTF6K0g https://t.co/mTqD7wneuE
244 followers
RT @jsabatino37: Very proud to share the pre-print of a study I co-led with Riley Bove, @ZamvilScott, and Michael Wilson looking at antibod…
238 followers
RT @jsabatino37: Very proud to share the pre-print of a study I co-led with Riley Bove, @ZamvilScott, and Michael Wilson looking at antibod…
776 followers
RT @jsabatino37: Very proud to share the pre-print of a study I co-led with Riley Bove, @ZamvilScott, and Michael Wilson looking at antibod…
709 followers
RT @jsabatino37: Very proud to share the pre-print of a study I co-led with Riley Bove, @ZamvilScott, and Michael Wilson looking at antibod…
1,029 followers
RT @jsabatino37: Very proud to share the pre-print of a study I co-led with Riley Bove, @ZamvilScott, and Michael Wilson looking at antibod…
727 followers
Very proud to share the pre-print of a study I co-led with Riley Bove, @ZamvilScott, and Michael Wilson looking at antibody and T cell responses following SARS-CoV-2 vaccination in MS patients on different DMTs. https://t.co/aMjyapiO44
2,311 followers
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity https://t.co/RNm677kWB8"
17,954 followers
Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity https://t.co/w9SkSPQYsS #medRxiv